 | Up a level |
Kiener, Mirjam; Chen, Lanpeng; Krebs, Markus; Grosjean, Joël; Klima, Irena; Kalogirou, Charis; Riedmiller, Hubertus; Kneitz, Burkhard; Thalmann, George; Snaar-Jagalska, Ewa; Spahn, Martin; Kruithof-de Julio, Marianna; Zoni, Eugenio (2019). miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. BMC cancer, 19(1), p. 627. BioMed Central 10.1186/s12885-019-5819-6
Kneitz, Burkhard; Krebs, Markus; Kalogirou, Charis; Schubert, Maria; Joniau, Steven; van Poppel, Hein; Lerut, Evelyne; Kneitz, Susanne; Scholz, Claus Jürgen; Ströbel, Philipp; Gessler, Manfred; Riedmiller, Hubertus; Spahn, Martin (2014). Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer research, 74(9), pp. 2591-2603. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-13-1606
Vergho, Daniel Claudius; Kneitz, Susanne; Kalogirou, Charis; Burger, Maximilian; Krebs, Markus; Rosenwald, Andreas; Spahn, Martin; Löser, Andreas; Kocot, Arkadius; Riedmiller, Hubertus; Kneitz, Burkhard (2014). Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava. PLoS ONE, 9(10), e109877. Public Library of Science 10.1371/journal.pone.0109877
Vergho, Daniel; Kneitz, Susanne; Rosenwald, Andreas; Scherer, Charlotte; Spahn, Martin; Burger, Maximilian; Riedmiller, Hubertus; Kneitz, Burkhard (2014). Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC cancer, 14, p. 25. BioMed Central 10.1186/1471-2407-14-25
Schubert, Maria; Spahn, Martin; Kneitz, Susanne; Scholz, Claus Jürgen; Joniau, Steven; Stroebel, Philipp; Riedmiller, Hubertus; Kneitz, Burkhard; Culig, Zoran (2013). Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer. PLoS ONE, 8(6), e65064. Public Library of Science 10.1371/journal.pone.0065064
Kalogirou, Charis; Spahn, Martin; Krebs, Markus; Joniau, Steven; Lerut, Evelyne; Burger, Maximilian; Scholz, Claus-Jürgen; Kneitz, Susanne; Riedmiller, Hubertus; Kneitz, Burkhard (2013). MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. International journal of molecular sciences, 14(11), pp. 21414-21434. MDPI 10.3390/ijms141121414
Vergho, Daniel Claudius; Loeser, Andreas; Kocot, Arkadius; Spahn, Martin; Riedmiller, Hubertus (2012). Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery. BMC research notes, 5, p. 5. London: Biomed Central 10.1186/1756-0500-5-264
